Annals of the New York Academy of Sciences
-
Ann. N. Y. Acad. Sci. · Sep 2009
Clinical TrialAn open-label study adding creatine monohydrate to ongoing medical regimens in patients with the fibromyalgia syndrome.
Fibromyalgia is an ill-defined condition that causes pain and disability but still lacks effective treatment. The aim of this open-label study was to assess the efficacy of administering a food supplement, creatine monohydrate, in an "add on" to existing therapies in patients with fibromyalgia. ⋯ These results deteriorated 4 weeks after stopping creatine therapy. The findings of this study are preliminary and limited due to the small sample and relatively high rate of dropouts.